Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,811 | Dovepress* | 7,150+ | 1,420 | 8,570 | |
| PubMed Central* | 661 | 272 | 933 | ||
| Totals | 7,811 | 1,692 | 9,503 | ||
| *Since 5 January 2017 | |||||
View citations on PubMed Central and Google Scholar